AVDL — Avadel Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.11bn
- $2.06bn
- $169.12m
Brief: ASL Strategic Value Fund Avadel Pharmaceuticals Should Immediately Retain An Investment Bank To Explore All Possible Alternatives, Including Sale
U.S. STOCKS ON THE MOVE-Astronics, Nike, Climb Bio
U.S. STOCKS ON THE MOVE-IonQ, Lennar, GH Research
Avadel dips after disappointing 2025 revenue outlook
Brief: Avadel Announces Grant Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Avadel Pharmaceuticals PLC expected to post a loss of 3 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-PSQ Holdings, Core Scientific, Keros
Avadel Pharmaceuticals falls after chief commercial officer resigns
Avadel Pharmaceuticals PLC reports results for the quarter ended September 30 - Earnings Summary
Avadel Pharmaceuticals PLC expected to post a loss of 6 cents a share - Earnings Preview
Avadel Pharmaceuticals PLC expected to post a loss of 6 cents a share - Earnings Preview
Brief: Avadel Pharmaceuticals To Provide A Corporate Update And Report Third Quarter 2024 Financial Results On November 12
Brief: Avadel Pharmaceuticals Announces Favorable Ruling In Administrative Procedure Act Litigation
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
Brief: Avadel Pharmaceuticals Announces FDA Approval Of Lumryz™ For The Treatment Of Cataplexy
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
Avadel Pharmaceuticals rises as FDA expands approval for sleep disorder drug
US FDA expands approval for Avadel's sleep disorder drug (updated)
US FDA expands approval for Avadel's sleep disorder drug